TL;DR
Today's drugs that slow Alzheimer's are antibodies given by infusion, often on a heavy schedule; the dream is a cheap pill taken once a day at home. On Nov. 16 a 1,535-person trial of a daily pill called AR1001 reported its results, and one of the two groups it was built to judge came back a win. The details, the numbers and our odds on what comes next are below the line. Subscribe to read them.
Below the line, for paid subscribers: The full story: where it stands, how we got here and what's dated next; our labeled speculation on what it adds up to; and every source.



